4D Molecular Therapeutics, Inc.

$11.03- (-)1Y +18.50%

As of Oct 26, 2026 close

Market cap: $775.10M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $6.96$16.93
Volume (live): -
Avg. volume (3M): 1.08M

4D Molecular Therapeutics, Inc. (FDMT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for 4D Molecular Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy

Based on 11 unique analysts

(15 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$30.57

+177.15% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest FDMT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 22, 2026	Matthew Caufield	HC Wainwright	Reiterates	Buy	$36.00
Oct 22, 2026	Daniel Giraldo	BofA Securities	Maintains	Buy	$33.00
Oct 22, 2026	Maxwell Skor	Morgan Stanley	Maintains	Hold	-
Oct 20, 2026	Joshua Schimmer	Cantor Fitzgerald	Maintains	Buy	$20.00
Oct 13, 2026	Eliana Merle	Barclays	Maintains	Buy	$28.00
Oct 7, 2026	Gautam Chukka	Chardan Capital	Maintains	Buy	$25.00
Oct 6, 2026	Gautam Chukka	Chardan Capital	Maintains	Buy	$25.00
Sep 29, 2026	Daniel Giraldo	BofA Securities	Reiterates	Buy	$29.00 → $33.00 +4.00 (+13.8%)
Sep 29, 2026	Judah Frommer	Morgan Stanley	Maintains	Hold	-
Sep 21, 2026	Eric Schmidt FCA	Cantor Fitzgerald	Upgrades	Buy	-
Sep 11, 2026	Eliana Merle	Barclays	Maintains	Buy	$28.00
Aug 14, 2026	Matthew Caufield	HC Wainwright	Reiterates	Buy	$36.00
Aug 14, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 14, 2026	Lisa Walter	RBC Capital	Reiterates	Buy	$35.00
Jul 31, 2026	Unknown Analyst	B Riley	Initiates	Buy	$37.00

Matthew Caufield

HC Wainwright

BuyReiterates

$36.00

Oct 22

Daniel Giraldo

BofA Securities

BuyMaintains

$33.00

Oct 22

Maxwell Skor

Morgan Stanley

HoldMaintains

Oct 22

Joshua Schimmer

Cantor Fitzgerald

BuyMaintains

$20.00

Oct 20

Eliana Merle

Barclays

BuyMaintains

$28.00

Oct 13

Gautam Chukka

Chardan Capital

BuyMaintains

$25.00

Oct 7

Gautam Chukka

Chardan Capital

BuyMaintains

$25.00

Oct 6

Daniel Giraldo

BofA Securities

BuyReiterates

$29.00 → $33.00

Sep 29

Judah Frommer

Morgan Stanley

HoldMaintains

Sep 29

Eric Schmidt FCA

Cantor Fitzgerald

BuyUpgrades

Sep 21

Eliana Merle

Barclays

BuyMaintains

$28.00

Sep 11

Matthew Caufield

HC Wainwright

BuyReiterates

$36.00

Aug 14

Zacks Equity Research

HoldInitiates Coverage

Aug 14

Lisa Walter

RBC Capital

BuyReiterates

$35.00

Aug 14

Unknown Analyst

B Riley

BuyInitiates

$37.00

Jul 31

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for FDMT?

The analyst consensus rating for FDMT is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for FDMT?

The average 12-month price target for FDMT is $30.57, representing an upside of 177.2% from the Oct 26, 2026 close of $11.03.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.